Sana Biotechnology

eGenesis is a biotechnology company based in Cambridge, MA, focused on addressing the critical shortage of transplantable organs and cells through its innovative multiplex gene editing and genome engineering platform. With a vision of a world where no one dies waiting for a transplant, they are pioneering advancements in xenotransplantation to develop human-compatible organs and cells, particularly targeting kidney and islet cell transplants. The company aims to transform solid organ and therapeutic cell transplantation to improve the lives of patients in need, their families, and healthcare providers. By leveraging cutting-edge gene editing technologies, eGenesis is committed to overcoming historical challenges associated with organ transplantation and creating new opportunities for patients facing serious diseases. Generated from the website

Kymera Therapeutics, based in Cambridge, is at the forefront of advancing targeted protein degradation to develop next-generation medicines. The company's innovative approach focuses on harnessing the power of protein degradation to create novel treatments for various diseases, promising a new era in medicine. Generated from their website's infomation

Arkuda is comprised of passionate and experienced team members who are dedicated to improving the lives of people affected by neurodegenerative disease. Armed with deep expertise in biology and the ab